CONMED Corporation (CNMD) financial statements (2021 and earlier)

Company profile

Business Address 525 FRENCH ROAD
UTICA, NY 13502
State of Incorp. NY
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 261833277366
Cash and cash equivalents 261833277366
Receivables177189182167148136130
Inventory, net of allowances, customer advances and progress billings195165155141136167148
Inventory195165155141136167148
Assets held-for-sale, not part of disposal group     3
Other undisclosed current assets45182116192937
Total current assets:417397374357331407381
Noncurrent Assets
Finance lease, right-of-use asset11
Operating lease, right-of-use asset2223
Property, plant and equipment111119113116122125133
Intangible assets, net (including goodwill)1,1201,151814817817569573
Goodwill618618400402398261256
Intangible assets, net (excluding goodwill)502533413415420308316
Regulated entity, other noncurrent assets  001  
Deferred income tax assets76
Deferred tax assets, net 54  
Other undisclosed noncurrent assets74786863551111
Total noncurrent assets:1,3351,3789951,001998705717
TOTAL ASSETS:1,7521,7751,3691,3581,3291,1131,098
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1031109676746963
Accounts payable53565342423524
Employee-related liabilities50544334323236
Taxes payable     33
Debt181418151011
Other liabilities68654659304952
Total current liabilities:190188161150114120116
Noncurrent Liabilities
Long-term debt and lease obligation, including:735755439472488269240
Long-term debt, excluding current maturities  439472488269240
Finance lease, liability00
Operating lease, liability 17
Other undisclosed long-term debt and lease obligation735738     
Liabilities, other than long-term debt11764107105146139161
Deferred tax liabilities, net8178119115112
Deferred income tax liabilities58 
Liability, pension and other postretirement and postemployment benefits 17     
Other liabilities59472627272449
Other undisclosed noncurrent liabilities 58     
Total noncurrent liabilities:852877546577634408401
Total liabilities:1,0431,065707727748528517
Stockholders' equity
Stockholders' equity attributable to parent709710662631581585581
Common stock0000000
Treasury stock, value(68)(81)(89)(94)(97)(101)(105)
Additional paid in capital383379342334329325320
Accumulated other comprehensive loss(64)(59)(56)(49)(59)(54)(40)
Retained earnings457471465440407415406
Total stockholders' equity:709710662631581585581
TOTAL LIABILITIES AND EQUITY:1,7521,7751,3691,3581,3291,1131,098

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues862955860796764719740
Revenue, net796764719740
Cost of revenue
(Cost of Goods and Services Sold)
(402)(430)(391)(365)(355)(337)(336)
Gross profit:460525469431408382404
Operating expenses(414)(446)(398)(384)(371)(331)(351)
Operating income:46797147385153
Nonoperating expense(0)(5)  (3) (1)
Foreign currency transaction loss, before tax      (1)
Other nonoperating expense(0)(5)  (3)  
Interest and debt expense(44)(43)(21)(18)(15)(6)(6)
Other undisclosed income from continuing operations before equity method investments, income taxes      1
Income from continuing operations before income taxes:2315129194547
Income tax expense (benefit)8(3)(10)27(5)(15)(14)
Net income available to common stockholders, diluted:10294155153032

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income:10294155153032
Other comprehensive income (loss)(4)254065101610
Other undisclosed comprehensive loss (29)(41)(55)(15)(30)(32)
Comprehensive income, net of tax, attributable to parent:5254065101610

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: